SLC45A3-ELK4 chimera in prostate cancer: Spotlight on cis-splicing

Cancer Discovery

Volumn 2, Issue 7, 2012, Pages 582-585

  Kumar Sinha, Chandan ^a   Kalyana Sundaram, Shanker ^a   Chinnaiyan, Arul M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR; HYBRID PROTEIN; REPRESSOR PROTEIN; SOLUTE CARRIER FAMILY 45 MEMBRANE 3; TRANSCRIPTION FACTOR ELK 4; UNCLASSIFIED DRUG;

ANDROGEN THERAPY; ARTICLE; BREAST CANCER; CARCINOMA; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; FOLLOW UP; GENE FUSION; HEMATOLOGIC MALIGNANCY; HIGH THROUGHPUT SEQUENCING; HUMAN; LUNG CANCER; MICROARRAY ANALYSIS; MOLECULARLY TARGETED THERAPY; NONHUMAN; POLYMERASE CHAIN REACTION; PROSTATE CANCER; REAL TIME POLYMERASE CHAIN REACTION; RNA SPLICING; SOFT TISSUE TUMOR; SOUTHERN BLOTTING; TRANS SPLICING; UPREGULATION;

ANIMALS; CELL PROLIFERATION; ETS-DOMAIN PROTEIN ELK-4; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; PROSTATIC NEOPLASMS; RECOMBINANT FUSION PROTEINS; RNA SPLICING;

EID: 84866319241     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-12-0212     Document Type: Article

References (20)

1. Wong S, Witte ON. The BCR-ABL story: bench to bedside and back. Annu Rev Immunol 2004;22:247-306.
2. Rowley JD. Chromosome translocations: dangerous liaisons revisited. Nat Rev Cancer 2001;1:245-50.
3. Rabbitts TH. Chromosomal translocations in human cancer. Nature 1994;372:143-9.
4. Chinnaiyan AM, Palanisamy N. Chromosomal aberrations in solid tumors. Prog Mol Biol Transl Sci 2010;95:55-94.
5. Rabbitts TH. Commonality but diversity in cancer gene fusions. Cell 2009;137:391-5.
6. Palanisamy N, Ateeq B, Kalyana-Sundaram S, Pflueger D, Ramnarayanan K, Shankar S, et al. Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. Nat Med 2010;16:793-8.
7. Robinson DR, Kalyana-Sundaram S, Wu YM, Shankar S, Cao X, Ateeq B, et al. Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. Nat Med 2011;17:1646-51.
8. Zhou J, Liao J, Zheng X, Shen H. Chimeric RNAs as potential biomarkers for tumor diagnosis. BMB Rep 2012;45:133-40.
9. Nacu S, Yuan W, Kan Z, Bhatt D, Rivers CS, Stinson J, et al. Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples. BMC Med Genomics 2011;4:11.
10. Rickman DS, Pflueger D, Moss B, VanDoren VE, Chen CX, de la Taille A, et al. SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer. Cancer Res 2009;69:2734-8.
11. Maher CA, Kumar-Sinha C, Cao X, Kalyana-Sundaram S, Han B, Jing X, et al. Transcriptome sequencing to detect gene fusions in cancer. Nature 2009;458:97-101.
12. Zhang Y, Gong M, Yuan H, Park HG, Frierson HF, Li H. Chimeric transcript generated by cis-splicing of adjacent genes regulates prostate cancer cell proliferation. Cancer Discov 2012;2:598-607.
13. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, et al. High-resolution profiling of histone methylations in the human genome. Cell 2007;129:823-37.
14. Burgess-Beusse B, Farrell C, Gaszner M, Litt M, Mutskov V, Recillas-Targa F, et al. The insulation of genes from external enhancers and silencing chromatin. Proc Natl Acad Sci U S A 2002;99 Suppl 4:16433-7.
15. Kornblihtt AR. CTCF: from insulators to alternative splicing regulation. Cell Res 2012;22:450-2.
16. Shukla S, Kavak E, Gregory M, Imashimizu M, Shutinoski B, Kashlev M, et al. CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature 2011;479:74-9.
17. Li H, Wang J, Mor G, Sklar J. A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells. Science 2008; 321:1357-61.
18. Carver BS, Tran J, Gopalan A, Chen Z, Shaikh S, Carracedo A, et al. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat Genet 2009;41:619-24.
19. Tomlins SA, Laxman B, Dhanasekaran SM, Helgeson BE, Cao X, Morris DS, et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 2007;448:595-9.
20. Kumar-Sinha C, Tomlins SA, Chinnaiyan AM. Recurrent gene fusions in prostate cancer. Nat Rev Cancer 2008;8:497-511.